Skip to main content

Animations

MJFF Publications

2221 - 2230 of 8620 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson's
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16180
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Large-scale rare variant burden testing in Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad214
    Citation Count: 35
  • Summary Details
    OPEN
    Title: How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad265
    Citation Count: 24
  • Summary Details
    OPEN
    Title: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-023-02080-x
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-42934-0
    Citation Count: 6
  • Summary Details
    OPEN
    Title: MRI-based multivariate gray matter volumetric distance for predicting motor symptom progression in Parkinson's disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-44322-0
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Adaptor protein-3 produces synaptic vesicles that release phasic dopamine
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2309843120
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Organ aging signatures in the plasma proteome track health and disease
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-023-06802-1
    Citation Count: 301
  • Summary Details
    OPEN
    Title: The elephant in the room: critical reflections on mortality rates among individuals with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00588-9
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-42876-1
    Citation Count: 43
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.